CUTE LYMPHOBLASTIC LEUKEmia (ALL) is the most common childhood malignancy in the United States, comprising 25% of all cancers in individuals younger than 20 years. 1 Over the past several decades, ALL has been transformed from a uniformly fatal disease to one that is associated with a 5-year survival probability of greater than 80%. 2 This remarkable progress is largely because of the adoption of risk-based therapy determined by patient characteristics and leukemia phenotype at disease presentation. Characteristics consistently identified from epidemiological studies to infer higher risk and require more intensive therapy include age at diagnosis (Ͻ1 year or Ն10 years), peripheral white blood cell (WBC) count greater than 50000/µL, T-cell immunophenotype, hypodiploidy, and certain chromosomal abnormalities. 3 Variability in survival outcome across racial and ethnic groups (hereafter referred to as race/ethnicity) also has been identified in some, but not all, clinical research. 4-13 Based on a study of St Jude's Children's Research Hospital data, Pui et al 4 concluded that survival in black children with ALL was comparable with that of white children with ALL in recent treatment eras, which are associated with more intensive, risk-based therapy. In contrast, Bhatia et al 5 reported that black and Hispanic children enrolled in Chil-dren's Cancer Group cooperative trials in the modern treatment era had worse survival than did white children, who in turn had worse survival than children of Asian decent, even after adjusting for other risk factors. The conclusions by Bhatia et al are similar to those of Pollock et al, 8 who found that black children and children with a Spanish surname enrolled in Pediatric Oncology Group cooperative trials had worse outcomes than white children. Population-based studies are needed to further delineate the role of race/ ethnicity in the risk classification of children with ALL. Past clinical studies were vulnerable to participation bias because they were restricted to children at a single medical center or those